期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱![]() | THYROID LetPub Score 8.4
50 ratings
Rate
Reputation 9.8 Influence 7.7 Speed 6.9 | ||||||||||||||||||||
期刊簡稱 | THYROID | ||||||||||||||||||||
ISSN | 1050-7256 | ||||||||||||||||||||
E-ISSN | 1557-9077 | ||||||||||||||||||||
h-index | 126 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 6.70%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://online.liebertpub.com/thy | ||||||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/thyroid | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Mary Ann Liebert Inc. | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||
創刊年 | 1990 | ||||||||||||||||||||
每年文章數 | 128每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 9.54% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1050-7256%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 6 Month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 25% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[THYROID] 的評論 | 撰寫評論 |
作者: 大力凝静 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-27 12:37:02 評論於 Pediatric thyroid cancer is a rare disease, with over 40 cases included. ![]() ![]() |
作者: 深渊孤兰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-22 14:11:07 評論於 Do you only collect the review fee after the decision to send it for review? What if the editor rejects the submission directly? ![]() ![]() |
作者: saltyandy 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2024-04-17 22:18:22 評論於 Submitted on April 15th, paid the review fee, and the next day the editor directly rejected the submission without sending it for external review. I wrote a letter to appeal and stated that the review fee cannot be refunded. Got scammed out of $90 like this ![]() ![]() |
作者: 宁蒙氏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-23 14:14:51 評論於 Focus of research: Epidemiology Experience sharing: Submitted an epidemiology paper, received $90 for peer review, first review took around 50 days, the waiting time was quite long. Although it was rejected, both reviewers read it carefully and provided detailed feedback, suggesting several directions for improvement ![]() ![]() |
作者: 暴风芮美 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-20 12:11:02 評論於 Can this be reimbursed? ![]() ![]() |
作者: Pandora Isaiah 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-30 18:17:35 評論於 Submission fee is $90, please consider carefully ![]() ![]() |
作者: 明冠芷文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-16 14:15:40 評論於 Is it a retrospective study? How many patients were enrolled? ![]() ![]() |
作者: 华清树行 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-20 23:11:19 評論於 Review speed: 3.0 | Submission acceptance rate: 25.0 Experience sharing: Submitted a paper on thyroid-related eye diseases and it took almost three months for review. Compared to the feedback given, the review speed can be considered very slow ![]() ![]() |
作者: 大力凝静 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-04 12:46:07 評論於 Review Speed: 1.0 | Submission Success Rate: 25.0 Focused Research Area: Children's Thyroid Cancer Experience Sharing: 27-Apr-2022 SUBMITTED 27-May-2022 Major Revision Accepted (04-Aug-2022 ![]() ![]() |
作者: 终幕长卿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-07 17:39:20 評論於 How did it all end in the end? ![]() ![]() |
作者: 终幕长卿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-02 16:51:31 評論於 Can any teacher share their process of handling manuscripts? ![]() ![]() |
作者: 终幕长卿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-30 15:27:39 評論於 What are the different statuses after the submission? Will it show as under review, and then completed review? ![]() ![]() |
作者: 卧龙天华 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-20 11:43:07 評論於 Review Speed: 2.0 | Submission Success Rate: 25.0 Experience Sharing: Received revisions two months after submission, requested to return within one month, lots of advice, very tight schedule ![]() ![]() |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:55:55 評論於 2 weeks - 3 months ![]() ![]() |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:09:40 評論於 Please translate the following paragraph into English and Japanese, and title them ":" and ":" respectively: Google translate ![]() ![]() |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 12:27:58 評論於 The journal sent me a letter, but I can't understand it. What should I do? ![]() ![]() |
作者: 上清雨真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 09:39:25 評論於 How long does it usually take for a journal to review a submission? ![]() ![]() |
作者: 淑亮mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-11 16:04:36 評論於 That submission fee of $90 is a bit expensive. Not reimbursed ![]() ![]() |
作者: 墟散湛静 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-20 13:50:26 評論於 Hello, I have encountered the same issue. Have you successfully paid the review fee? ![]() ![]() |
作者: 云来桐欣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-08 10:37:20 評論於 Hello, has your issue been resolved? I also encountered the same problem ![]() ![]() |
作者: 云来桐欣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-08 08:52:13 評論於 Hello, I encountered an error when submitting the payment fee. How did you solve the payment issue? Can you tell me? ![]() ![]() |
作者: 云来桐欣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-08 08:36:24 評論於 Hello, has your problem been resolved? I have encountered the same issue as well ![]() ![]() |
作者: 紫晨超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-31 11:51:03 評論於 You can submit an overview ![]() ![]() |
作者: 空明霏霏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-26 11:05:27 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 | Review fee: 90.0 Emphasized research areas: Epidemiology; Ecological studies; Sharing experiences on thyroid cancer: Submitted on 2021.04.30, rejected on 05.27. Two reviewers suggested to be gentle and detailed, it is still worth trying to submit again ![]() ![]() |
作者: 是涵蓄吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-09-04 16:47:51 評論於 Hello, has the issue been resolved? I have also encountered the same problem ![]() ![]() |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us